Bixiye
QP70-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective November 1, 2021
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1771 - 1780 ee natiijooyinka 3613
Bixiye
QP65R1-21 Update: Minnesota Health Care Programs Providers use of the Interactive Care Reviewer
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021
Bixiye
QP69-21 Update for New to Market Medical Drugs: Ciltacabtagene Autoleucel
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021
Bixiye
2021 September Bulletins
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2021
Bixiye
P49-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2021
Bixiye
P51-21 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2021
Bixiye
P50-21 eviCore Healthcare Specialty Utilization Management (UM) Program Radiation Oncology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2021
Bixiye
P52-21 Introduction of New Self-Insured Product
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2021
Bixiye
QP67-21 Commercial Pharmacy Benefit Exclusion for Mifeprex
Taariikhda barnaamijka Dhaqangalayso Agosto 25, 2021